GSK PLC's ticker is and the CUSIP is 37733W204. A total of 838 filers reported holding GSK PLC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,160 | -10.2% | 160 | 0.0% | 0.01% | -16.7% |
| Q1 2024 | $6,859 | +15.7% | 160 | 0.0% | 0.01% | 0.0% |
| Q4 2023 | $5,930 | +2.2% | 160 | 0.0% | 0.01% | -14.3% |
| Q3 2023 | $5,800 | +1.7% | 160 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $5,702 | +0.2% | 160 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $5,693 | +94783.3% | 160 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $6 | -100.0% | 160 | -78.1% | 0.01% | -75.9% |
| Q3 2022 | $21,000 | – | 729 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |